You are here: Home » News-CM » Companies » News
Business Standard

Orchid Pharma receives EIR report on closure of PADE inspection

Capital Market 

By USFDA

Orchid has received the Establishment Inspection Report from USFDA based on the successful inspection closure for the Post-marketing Adverse Drug Experience reporting Inspection (PADE) conducted at 313, Valluvar Kottam High Road, Nungambakkam, Chennai. The facility was inspected by USFDA in the month of June 2017.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Mon, January 08 2018. 19:58 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU